Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a minor update to the page’s metadata.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page shows a revision tag that updates the version from v3.5.2 to v3.5.3, representing a minor update to the page; the core study details and layout remain the same.
    Difference
    0.1%
    Check dated 2026-04-30T16:31:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:10:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Waldenström macroglobulinemia is now listed as a condition on the page, and a Resources section has been added with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:22:27.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed; this appears to be a backend/UI update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:36.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:18:45.000Z thumbnail image

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.